LDN Compounding Opportunities: Post-COVID, Autoimmune, Dermatology, and More
LDN
•
2h 15m
Run time: 2 hour 15 minutes
Download handout: https://bit.ly/3P7ZGhY
This compilation of four presentations from PCCA’s Clinical Compounding Pharmacists will feature presentations covering formulas to help with symptoms related to Parkinson’s Disease, Multiple Sclerosis, ALS, Hashimoto’s and Lupus. Topics related to long term complications associated with COVID-19 and the role of LDN will be addressed as well as new literature on the use of naltrexone in various conditions. Content on topical versus transdermal delivery of naltrexone and dermatological conditions will also be discussed.
Up Next in LDN
-
LDN and Its Use in Memory Loss and Ca...
Run time: 1 hour 8 minutes
Download handout: https://bit.ly/3P7Zz62During this presentation, Dr. Pam Smith will share LDN uses in treating memory loss and cancer. After watching this presentation, the viewer should be able to:
- Describe various causes of inflammation and the role inflammation ... -
What Works for Me: How I Market LDN t...
Run time: 1 hour 6 minutes
Download handout: https://bit.ly/3Ij3oBPDuring this presentation, PCCA members Katie Lewis, Stacy Hightower, and Michael Stevelman will share what works for them when marketing LDN to practitioners.
-
Low-Dose Naltrexone: What's New
Join us to discover the latest and greatest in naltrexone compounding with PCCA Clinical Compounding Pharmacist Sebastian Denison, RPh. He'll share updated information you need to know, plus uncover new compounding options to grow your practice.
You'll learn:
New and updated LDN dosing consider...
